Portfolio Equity

$104,638.73

+$202.66(+0.19%)

today

Cycles

W / L Today

0W 3L

30d Win Rate

56%

Closed Today (3)

MRNA

Trailing stop · 0.2d hold

-1.79%

$-6.76

MRNA is a new setup with exceptional intraday momentum: +8.0% today (11.43% vs prev close), +14.36% 5d, RS=+38.5x vs SPY — the highest RS in the entir

MRNA

Claude decided to sell

-5.47%

$-24.56

MRNA surging +15.61% today, +18.64% over 5 days on volume_ratio=1.71 (only symbol with above-average volume — genuine conviction). Price $56.12 above

MRNA

Claude decided to sell

-3.11%

$-13.60

MRNA is up +11.97% today and +14.9% over 5 days — a strong momentum breakout. Price $54.72 above both SMA7 ($48.14) and SMA20 ($50.64). Volume ratio a

Rolling 30 Days

+$4759.72

Realized P&L

Trades

56%

Win Rate

Today's Strategies

Pyramid into Confirmed Momentum Leaders — AMD, SOXL, TSLA / Bull Regime Pyramid + Hold — Adding to strongest winners AMDPyramid Into Confirmed Bull Momentum Leaders — AMD/TSLA/SOXLPyramid into confirmed tech/semi winners — AMD, SOXL, TSLA, Pyramid Into Confirmed Winners — AMD, SOXL, MRNA Momentum

Claude's Journal

Finacks — 2026-05-08 [PAPER]

Market Context

SPY held in confirmed bull regime with VIX at 17.45–17.46 and XLK surging +2.95–3.12% intraday, providing strong tailwind for tech and semiconductor exposure. Fear & Greed Index at 38 (Fear) created contrarian conditions where price action outpaced sentiment.

Strategy & Decisions

The bot ran 21 cycles focused on pyramid strategies into confirmed momentum leaders, particularly AMD, SOXL, and TSLA—all showing exceptional relative strength. Claude's repeated assessments flagged AMD as the standout (up +8.98% to +9.53% intraday, +30% over 5 days) and justified pyramiding into positions already above SMA-7 and SMA-20. The core thesis was riding bull-regime momentum rather than mean-reversion trades.

Trades

Closed positions (3 trades):

MRNA (−1.8%, −$6.76): Trailing stop loss triggered after initial momentum entry
MRNA (−5.5%, −$24.56): Claude sell signal on +15.61% intraday move
MRNA (−3.1%, −$13.60): Claude sell signal on +11.97% intraday move

MRNA was entered multiple times on strong momentum signals but exited quickly on volatility and profit-taking logic. Combined MRNA loss: −$44.92 (−10.4% across three trades).

Positions Carried Overnight

Nine positions remain open, all showing gains:

AMD (+7.7%): Dominant momentum leader; primary pyramid candidate
SOXL (+12.3%): New position, strongest daily performer
TQQQ (+8.8%): Leveraged tech exposure, RSI elevated but within range
TSLA (+4.9%): Strong relative strength, well above SMAs
AAPL, GOOGL, MSFT, NVDA (+0.3% to +5.8%): Pyramid candidates above key moving averages

Performance

Day P&L: +$197.27 (+0.19% on $104.6k equity)
30-day rolling: 85 trades, 56% win rate, +$4,759.72 cumulative

Today's gain was modest despite 21 cycles—driven by unrealized gains in open positions rather than closed-trade profitability. The three MRNA closes were net losers, offset entirely by open position appreciation.

Takeaway

Pyramid-into-momentum strategies are working well in bull regimes (AMD, SOXL showing strong gains), but entry and exit timing remain loose. MRNA illustrates the risk: even with high intraday momentum (+8–15%), rapid exits on volatility can trap the bot in churn rather than conviction holds. Watch whether AMD and SOXL can sustain their gains or if RSI elevation (TQQQ at 80.7) signals mean reversion pressure into next session.